Collegium Pharmaceutical, Inc. Common Stock (COLL) Stock Price

COLLStock

$23.19−30.17%52W

Market Cap$754.96M

P/E12.01x

PEG Ratio0.67

Div yield—

Beta0.75

COLL Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-44.84%

Price vs S&P 500 (4W)1.98%

PEG Ratio0.67

VGM Score64.15

P/E Ratio (Annual)12.01x

P/CF (Annual)2.29x

Book Value / Share (Quarterly)$9.60

P/TBV (Annual)11.92x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)18.94%

Cash Flow / Share (Quarterly)$10.10

Price vs S&P 500 (YTD)-61.84%

Gross Margin (TTM)60.02%

Net Profit Margin (TTM)5.93%

EPS (TTM)$1.11

10-Day Avg Trading Volume0.72M

EPS Excl Extra (TTM)$1.11

Revenue Growth (5Y)20.28%

EPS (Annual)$1.58

ROI (Annual)5.10%

Gross Margin (Annual)59.35%

Net Profit Margin (5Y Avg)9.59%

Cash / Share (Quarterly)$3.98

P/E Basic Excl Extra (TTM)15.76x

Revenue Growth QoQ (YoY)6.32%

EPS Growth (5Y)15.77%

P/E Normalized (Annual)12.01x

ROA (Last FY)3.79%

Revenue Growth TTM (YoY)14.31%

EBITD / Share (TTM)$3.82

ROE (5Y Avg)19.62%

Operating Margin (TTM)17.50%

Cash Flow / Share (Annual)$10.33

P/B Ratio2.42x

P/B Ratio (Quarterly)3.76x

Net Income / Employee (Annual)$148,600

EV / Revenue (TTM)2.27x

Net Interest Coverage (TTM)2.30x

ROA (TTM)2.72%

EPS Growth QoQ (YoY)391.58%

EV / EBITDA (TTM)12.62x

EPS Incl Extra (Annual)$1.58

Current Ratio (Annual)1.57x

Quick Ratio (Quarterly)0.74x

3-Month Avg Trading Volume0.69M

52-Week Price Return-30.17%

EV / Free Cash Flow (Annual)5.61x

P/E Incl Extra (TTM)15.76x

Revenue / Employee (TTM)$1,910,700

Tangible BV / Share (Quarterly)$1.72

P/S Ratio (Annual)0.97x

Asset Turnover (Annual)0.47x

52-Week High$50.79

Operating Margin (5Y Avg)16.98%

EPS Excl Extra (Annual)$1.58

CapEx CAGR (5Y)-65.83%

26-Week Price Return-34.93%

Quick Ratio (Annual)1.41x

13-Week Price Return-35.73%

Total Debt / Equity (Annual)3.09x

Current Ratio (Quarterly)1.03x

Enterprise Value$1.84B

Revenue / Share Growth (5Y)17.42%

Asset Turnover (TTM)0.46x

Book Value / Share Growth (5Y)12.10%

Revenue / Employee (Annual)$1,845,300

Inventory Turnover (Annual)8.30x

Pretax Margin (Annual)11.87%

Cash / Share (Annual)$12.20

3-Month Return Std Dev51.63%

Gross Margin (5Y Avg)55.45%

Net Income / Employee (TTM)$113,300

EBITDA CAGR (5Y)24.06%

EBITDA Interim CAGR (5Y)-20.08%

ROE (Last FY)20.84%

Net Interest Coverage (Annual)2.22x

EPS Basic Excl Extra (Annual)$1.58

P/FCF (TTM)2.30x

Receivables Turnover (TTM)3.25x

EV / Free Cash Flow (TTM)5.60x

Total Debt / Equity (Quarterly)3.89x

EPS Incl Extra (TTM)$1.11

Receivables Turnover (Annual)3.55x

ROI (TTM)3.69%

P/S Ratio (TTM)0.93x

Pretax Margin (5Y Avg)6.68%

Revenue / Share (Annual)$19.66

Tangible BV / Share (Annual)$1.72

Forward P/E3.34x

Free OCF CAGR (5Y)56.88%

Price vs S&P 500 (52W)-45.70%

P/E Ratio (TTM)15.76x

EPS Growth TTM (YoY)20.82%

Year-to-Date Return-49.91%

5-Day Price Return5.17%

EPS Normalized (Annual)$1.58

ROA (5Y Avg)4.07%

Net Profit Margin (Annual)8.05%

Month-to-Date Return6.28%

Cash Flow / Share (TTM)$4.22

EBITD / Share (Annual)$4.23

EPS Growth (3Y)-0.62%

Operating Margin (Annual)20.96%

LT Debt / Equity (Annual)2.99x

P/CF (TTM)2.29x

ROI (5Y Avg)5.89%

P/E Excl Extra (TTM)15.76x

LT Debt / Equity (Quarterly)3.71x

EPS Basic Excl Extra (TTM)$1.11

P/TBV (Quarterly)11.92x

P/B Ratio (Annual)4.85x

Inventory Turnover (TTM)4.27x

Pretax Margin (TTM)9.61%

Book Value / Share (Annual)$9.51

Price vs S&P 500 (13W)-38.41%

Net Margin Growth (5Y)-1.43%

Beta0.75x

P/FCF (Annual)2.30x

Revenue / Share (TTM)$24.90

ROE (TTM)15.96%

52-Week Low$21.43

vGradeB

gGradeB

mGradeC

vgmGradeB

COLL Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	$1.76	$1.92	+8.78%(+$0.16)
Q1 2026	May 7, 2026	$1.52	$1.76	+15.52%(+$0.24)
Q4 2025	Feb 26, 2026	$2.14	$2.04	-4.66%(-$0.10)
Q3 2025	Nov 6, 2025	$1.86	$2.25	+20.97%(+$0.39)
Q2 2025	Aug 7, 2025	$1.85	$1.68	-9.19%(-$0.17)

COLL Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.08

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
COLLCollegium Pharmaceutical, Inc. Common Stock	B	B	C	0.9x	14.3%	60.0%	15.8%	$23.19
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About Collegium Pharmaceutical, Inc. Common Stock

Collegium Pharmaceutical is a biopharmaceutical company that develops and commercializes treatments for ADHD and moderate to severe pain in the United States. Its marketed product portfolio includes Jornay PM for ADHD, Belbuca and Xtampza ER for pain management, the Nucynta line (Nucynta ER and IR), and Symproic.